Research has reported that ADAM33 is linked with alterations in airway structure among asthma patients, resulting in heightened responsiveness, constriction of the airways, and ultimately diminished therapeutic efficacy (Vishweswaraiah et al. 2023). Here, ADAM33 is linked to asthma.